Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease

Movement Disorders

Volumn 28, Issue 8, 2013, Pages 1142-1145

  Hart, Ellen P ^a   Marinus, Johan ^a   Burgunder, Jean Marc ^b   Bentivoglio, Anna Rita ^c   Craufurd, David ^d   Reilmann, Ralf ^e   Saft, Carsten ^f   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Chorea; Cognition; Huntington's disease; Hyperkinetic; Hypokinetic

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; COGNITION; DISEASE DURATION; FEMALE; FUNCTIONAL STATUS; HUMAN; HUNTINGTON CHOREA; HYPOKINESIA; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; UNIFIED HUNTINGTON DISEASE RATING SCALE;

CHOREA; COGNITION; HUNTINGTON'S DISEASE; HYPERKINETIC; HYPOKINETIC;

ADULT; COGNITION DISORDERS; DISABILITY EVALUATION; EUROPE; FEMALE; HUMANS; HUNTINGTON DISEASE; HYPOKINESIA; MALE; MIDDLE AGED; MUSCLE RIGIDITY; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84881555842     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25422     Document Type: Article

References (21)

1. HDCRG. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72:971-983.
2. Tabrizi SJ, Scahill RI, Durr A, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 2011;10:31-42.
3. Roos RA. Huntington's disease: a clinical review. Orphanet J Rare Dis 2010;5:40.
4. van Vugt JP, Siesling S, Piet KK, et al. Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease. Mov Disord 2001;16:481-488.
5. van Vugt JP, van Hilten BJ, Roos RA. Hypokinesia in Huntington's disease. Mov Disord 1996;11:384-388.
6. Nance MA, Myers RH. Juvenile onset Huntington's disease-clinical and research perspectives. Ment Retard Dev Disabil Res Rev 2001;7:153-157.
7. Sturrock A, Leavitt BR. The clinical and genetic features of Huntington disease. J Geriatr Psychiatry Neurol 2010;23:243-259.
8. Sanchez-Pernaute R, Kunig G, del Barrio AA, et al. Bradykinesia in early Huntington's disease. Neurology 2000;54:119-125.
9. Girotti F, Marano R, Soliveri P, et al. Relationship between motor and cognitive disorders in Huntington's disease. J Neurol 1988;235:454-457.
10. Thompson PD, Berardelli A, Rothwell JC, et al. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 1988;111:223-244.
11. Young AB, Shoulson I, Penney JB, et al. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 1986;36:244-249.
12. Brandt J, Strauss ME, Larus J, et al. Clinical correlates of dementia and disability in Huntington's disease. J Clin Neuropsychol 1984;6:401-412.
13. Klempir J, Klempirova O, Stochl J, et al. The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease. J Neurol 2009;256:1629-1633.
14. Reedeker N, van der Mast RC, Giltay EJ, et al. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning. Mov Disord 2010;25:1612-1618.
15. Mahant N, McCusker EA, Byth K, et al. Huntington's disease: clinical correlates of disability and progression. Neurology 2003;61:1085-1092.
16. Frank S. Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. Neuropsychiatr Dis Treat 2010;6:657-665.
17. Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011;10:83-98.
18. UHDRS. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 1996;11:136-142.
19. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529-1534.
20. van Rooden SM, Visser M, Verbaan D, et al. Motor patterns in Parkinson's disease: a data-driven approach. Mov Disord 2009;24:1042-1047.
21. Penney JB Jr, Young AB, Shoulson I, et al. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 1990;5:93-99.